Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$1.14B |
| 2 |
UnitedHealth
UNH
|
+$391M |
| 3 |
Meta Platforms (Facebook)
META
|
+$310M |
| 4 |
Wabtec
WAB
|
+$296M |
| 5 |
Elanco Animal Health
ELAN
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$518M |
| 2 |
Coca-Cola
KO
|
+$358M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$323M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$303M |
| 5 |
Starbucks
SBUX
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 17.92% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 11.03% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ROIC
926
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $9.05M | 0.01% |
+521,681
| New | +$8.91M |
|
927
Hawaiian Electric Industries
HE
$2.28B
| $8.98M | 0.01% |
220,237
+15,471
| +8% | +$588K |
|
928
Precision BioSciences
DTIL
$185M
| $8.97M | 0.01% |
+16,667
| New | +$8.85M |
|
929
Mettler-Toledo International
MTD
$28.1B
| $8.89M | ﹤0.01% |
12,301
+6,418
| +109% | +$4.17M |
|
930
Fidelity National Financial
FNF
$14.6B
| $8.8M | ﹤0.01% |
250,435
-128,275
| -34% | -$4.3M |
|
|
FRC
931
DELISTED
First Republic Bank
FRC
| $8.57M | ﹤0.01% |
85,335
-12,862
| -13% | -$1.27M |
|
932
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $8.45M | ﹤0.01% |
168,470
+115,203
| +216% | +$5.64M |
|
933
PACCAR
PCAR
$72.7B
| $8.25M | ﹤0.01% |
181,668
+56,730
| +45% | +$2.47M |
|
934
Plains GP Holdings
PAGP
$5.2B
| $8.13M | ﹤0.01% |
326,427
-422,367
| -56% | -$9.98M |
|
|
HRC
935
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.08M | ﹤0.01% |
76,360
+52,301
| +217% | +$5.27M |
|
936
McKesson
MCK
$104B
| $8.01M | ﹤0.01% |
68,455
+17,845
| +35% | +$2.2M |
|
937
J.M. Smucker
SJM
$13.2B
| $7.85M | ﹤0.01% |
67,353
+30,690
| +84% | +$3.21M |
|
938
Ionis Pharmaceuticals
IONS
$9.14B
| $7.83M | ﹤0.01% |
96,518
+84,587
| +709% | +$5.46M |
|
|
SJR
939
DELISTED
Shaw Communications Inc.
SJR
| $7.79M | ﹤0.01% |
374,298
+4,064
| +1% | +$82.4K |
|
940
Sprouts Farmers Market
SFM
$7.31B
| $7.74M | ﹤0.01% |
359,539
-148,214
| -29% | -$3.48M |
|
941
Pembina Pipeline
PBA
$29B
| $7.73M | ﹤0.01% |
210,253
+73,858
| +54% | +$2.61M |
|
942
Rockwell Automation
ROK
$52.4B
| $7.7M | ﹤0.01% |
43,888
+12,435
| +40% | +$2.11M |
|
943
NVR
NVR
$17.3B
| $7.63M | ﹤0.01% |
2,761
+1,518
| +122% | +$4M |
|
944
Phibro Animal Health
PAHC
$1.48B
| $7.6M | ﹤0.01% |
230,340
+219,165
| +1,961% | +$6.82M |
|
945
State Street
STT
$50.2B
| $7.55M | ﹤0.01% |
114,677
-2,636
| -2% | -$183K |
|
946
Charles River Laboratories
CRL
$11.6B
| $7.32M | ﹤0.01% |
50,383
-30,682
| -38% | -$4.03M |
|
947
Boston Properties
BXP
$11.2B
| $7.28M | ﹤0.01% |
54,345
+17,051
| +46% | +$2.19M |
|
|
TRCO
948
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $7.03M | ﹤0.01% |
152,335
+90,040
| +145% | +$4.14M |
|
949
International Paper
IP
$23.3B
| $6.91M | ﹤0.01% |
157,691
+51,340
| +48% | +$2.23M |
|
950
Baker Hughes
BKR
$58B
| $6.83M | ﹤0.01% |
246,190
+82,964
| +51% | +$2.1M |
|
Similar funds
Janus Henderson Group's Q1 2019 Portfolio in Review
As of Q1 2019, Janus Henderson Group held 1,435 positions worth $180B, up 15% from $157B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q1 2019 filing shows 105 new, 637 increased, 574 reduced and 94 closed positions. Its largest new stake was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M. The largest sale was Celgene Corp, an estimated $518M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2019 buy was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M.
- Janus Henderson Group added most to Walt Disney in Q1 2019, an estimated $1.14B increase.
- Janus Henderson Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $518M.
- Janus Henderson Group fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $323M.
- Janus Henderson Group's ten largest holdings make up 17% of its $180B portfolio in Q1 2019.
- Janus Henderson Group opened 105 new positions and closed 94 in Q1 2019.
- Janus Henderson Group's portfolio value rose 15% quarter-over-quarter to $180B.
Based on Janus Henderson Group's 13F filing for Q1 2019, filed 30 Apr 2019.